|
⚲
|
| Signpath Pharma Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001455694 |
| Sale | 2009-02-19 |
| Fund | |
| Phone | 2677720107 |
| Address | 1375 California Road Quakertown, 18951 |
| Source | [EDGAR] |
| Fund AUM and Sold ($) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Arthur Bollon | |
| Meyers Associates LP | |
| Lawrence Helson |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
FA Fund II, a series of Komal Sethi Investments, LP
✚
|
0.0 | |
|
FA Gaingels Fund I, a series of DV Deals, LP
✚
|
0.0 | |
|
Falcon Heights Syndicate LLC
✚
|
0.0 | |
|
FI Fund I, a series of GSBacker Fund, LP
✚
|
0.0 | |
|
FI Fund I, a series of Nate Lipscomb, LP
✚
|
0.0 | |
|
FA2 Fund I, a series of Roll Up Vehicles, LP
✚
|
0.0 | |
|
FI Fund I, a series of Cleo Capital AL Vehicles, LP
✚
|
0.0 | |
|
FAS Fund I, a series of Unpopular VC, LP
✚
|
0.0 | |
|
FASS Michael Glenn
✚
|
0.0 | |
|
FACT, Inc.
✚
|
0.0 |